William Blair Initiates Coverage On Tandem Diabetes Care with Outperform Rating

Benzinga Newsdesk www.benzinga.com Positive 63.9%

Neg 0% Neu 0% Pos 63.9%

William Blair analyst Steven Lichtman initiates coverage on Tandem Diabetes Care (NASDAQ:TNDM) with a Outperform rating.